Global Study Finds Increased Risk of Heart and Brain Disorders Linked to COVID Vaccines
2 min read
Chart Showing Health Conditions After Covid Vaccine (Photo By The Global Covid Vaccine Safety (GCoVS) Project)
United States (The Lake Tribune) – The largest study on COVID-19 vaccine safety to date has unearthed an increase in the risk of certain neurological, blood, and heart disorders among vaccine recipients. This comprehensive research, spearheaded by an international coalition of vaccine experts, analyzed health outcomes in 99 million individuals vaccinated across eight countries, exploring the incidence of 13 medical conditions post-vaccination.
The study found a notably higher risk of five medical conditions, including Guillain-Barre syndrome, an autoimmune disorder causing nerve damage, in recipients of Pfizer, Moderna, and AstraZeneca vaccines. Despite these findings, the absolute risk to individuals remains low, with approximately 2,000 cases reported among the 13 billion doses administered globally.
Dr. Harlan Krumholz, a lead investigator and director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation, emphasized the dual reality of vaccines: their ability to save millions of lives while adversely affecting other individuals. The research highlighted a two to threefold increase in the risk of Guillain-Barre syndrome and myocarditis, particularly in young men, attributed to the body’s immune response to the mRNA vaccines.
Additionally, the study reported increased risks of Acute Disseminated Encephalomyelitis (ADEM), pericarditis, and Cerebral Venous Sinus Thrombosis (CVST) following vaccination, urging further investigation into these associations. Despite these concerns, the researchers claimed a significantly higher risk of neurological events following SARS-CoV-2 infection compared to vaccination, to reinforce the vaccines.
Experts not involved in the study, like Dr. Marc Siegel and Dr. Jacob Glanville, highlighted the importance of a risk-benefit analysis when considering vaccination, pointing out that the potential side effects of COVID-19 far outweigh the rare risks associated with vaccines.
The study, published in the journal Vaccine, is part of the broader Global COVID Vaccine Safety (GCoVS) Project, supported by the CDC. With over 80% of the U.S. population having received at least one dose of the vaccine, the findings contribute to the ongoing evaluation of vaccine safety and efficacy.
For more Data and to review this study visit the link here.
Follow The Lake Tribune on NewsBreak for More Reliable News Your Feed
